Infection of sympathetic and sensory neurones with herpes simplex virus does not elicit a shut-off of cellular protein synthesis: implications for viral latency and herpes vectors

By Nichol P.F.   Chang J.Y.   Johnson Jr E.M.   Olivo P.D.  

Neurobiology of Disease, Vol. 1, Iss. 1, 1994-11 ,pp. : 83-94

Academic Press

Access to resources Recommend Favorite

Gene therapy for treatment of cerebral ischemia using defective herpes simplex viral vectors

By Yenari Midori A.   Dumas Theodore C.   Sapolsky Robert M.   Steinberg Gary K.  

Neurological Research, Vol. 23, Iss. 5, 2001-07 ,pp. : 543-552

Maney Publishing

Access to resources Recommend Favorite

Helper Virus-Free Herpes Simplex Virus-1 Plasmid Vectors for Gene Therapy of Parkinson's Disease and Other Neurological Disorders

By Geller A.I.   Yu L.   Wang Y.   Fraefel C.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 98-102

Elsevier

Access to resources Recommend Favorite

Engineering Herpes Simplex Virus Vectors for CNS Applications

By Wolfe D.   Goins W.F.   Yamada M.   Moriuchi S.   Krisky D.M.   Oligino T.J.   Marconi P.C.   Fink D.J.   Glorioso J.C.  

Experimental Neurology, Vol. 159, Iss. 1, 1999-09 ,pp. : 34-46

Elsevier

Access to resources Recommend Favorite

Protective effect of herpes simplex virus‐mediated neurotrophin gene transfer in cisplatin neuropathy

By Chattopadhyay Munmun  

Brain, Vol. 127, Iss. 4, 2004-04 ,pp. : 929-939

Oxford University Press

Access to resources Recommend Favorite